This NSDUH report presents results of a survey of illicit substance, alcohol, and tobacco use among people 12 years of age and older. It Includes national estimates of the rates of use, trends, numbers of users, and other measures, such as youth-related prevention measures.

This NSDUH report presents national estimates on the prevalence of mental illness and the use mental health services among people ages 12 and older. The report includes data on co-occurring mental illness with substance use.

This report examines trends in illicit substance use from 2010 to 2011 and from 2002 to 2011 among Americans 12 and older, comparing differences by age group and gender. It also discusses disparities in the need for specialized treatment versus those who actually receive it.

This advisory answers questions about the seriousness of prescription drug misuse. It explains how people become dependent on prescription drugs, and treatment options. The advisory also offers necessary treatment resources for professionals.

This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.

This resource provides substance use treatment program administrators with information to implement tobacco-free policies and practices in treatment settings. It discusses challenges and strategies for developing clinical guidelines for treating tobacco dependence.

This advisory offers addiction counselors an introduction to tobacco use cessation during substance use treatment. It discusses screening and effective treatment approaches to quitting, and practical and supportive counseling.

This advisory equips substance use treatment and service providers with information about eating disorders and their relationship to substance use disorders. It provides an overview of screening, referrals, and evidence-based treatments for eating disorders and lists resources for more information.

This advisory defines protracted withdrawal and identifies specific withdrawal symptoms associated with alcohol, opioids, methamphetamine, cocaine, marijuana, and benzodiazepines. The advisory also explains how protracted withdrawal differs from acute withdrawal, and gives tips to help clients manage it in recovery.